328 related articles for article (PubMed ID: 22494798)
1. Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids.
Fazzi P; Manni E; Cristofani R; Cei G; Piazza S; Calabrese R; Antonelli A; Siciliano G; Barachini P; Carpi A
Biomed Pharmacother; 2012 Jun; 66(4):300-7. PubMed ID: 22494798
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cutaneous sarcoidosis with thalidomide.
Nguyen YT; Dupuy A; Cordoliani F; Vignon-Pennamen MD; Lebbé C; Morel P; Rybojad M
J Am Acad Dermatol; 2004 Feb; 50(2):235-41. PubMed ID: 14726878
[TBL] [Abstract][Full Text] [Related]
3. [Sarcoidosis: thalidomide treatment in ten patients].
Estines O; Revuz J; Wolkenstein P; Bressieux JM; Roujeau JC; Cosnes A
Ann Dermatol Venereol; 2001 May; 128(5):611-3. PubMed ID: 11427794
[TBL] [Abstract][Full Text] [Related]
4. Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis.
Pignone AM; Rosso AD; Fiori G; Matucci-Cerinic M; Becucci A; Tempestini A; Livi R; Generini S; Gramigna L; Benvenuti C; Carossino AM; Conforti ML; Perfetto F
J Pineal Res; 2006 Sep; 41(2):95-100. PubMed ID: 16879313
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
Cuadrado MJ; Karim Y; Sanna G; Smith E; Khamashta MA; Hughes GR
Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement.
Oliver SJ; Kikuchi T; Krueger JG; Kaplan G
Clin Immunol; 2002 Mar; 102(3):225-36. PubMed ID: 11890709
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide for chronic sarcoidosis.
Baughman RP; Judson MA; Teirstein AS; Moller DR; Lower EE
Chest; 2002 Jul; 122(1):227-32. PubMed ID: 12114363
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide.
Carlesimo M; Giustini S; Rossi A; Bonaccorsi P; Calvieri S
J Am Acad Dermatol; 1995 May; 32(5 Pt 2):866-9. PubMed ID: 7722046
[TBL] [Abstract][Full Text] [Related]
9. A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis.
Droitcourt C; Rybojad M; Porcher R; Juillard C; Cosnes A; Joly P; Lacour JP; D'Incan M; Dupin N; Sassolas B; Misery L; Chevrant-Breton J; Lebrun-Vignes B; Desseaux K; Valeyre D; Revuz J; Tazi A; Chosidow O; Dupuy A
Chest; 2014 Oct; 146(4):1046-1054. PubMed ID: 24945194
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of infliximab on refractory sarcoidosis.
Ørum M; Hilberg O; Krag S; Bendstrup E
Dan Med J; 2012 Dec; 59(12):A4535. PubMed ID: 23290282
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous sarcoidosis successfully treated with low doses of thalidomide.
Rousseau L; Beylot-Barry M; Doutre MS; Beylot C
Arch Dermatol; 1998 Aug; 134(8):1045-6. PubMed ID: 9722748
[No Abstract] [Full Text] [Related]
12. Inhaled budesonide for maintenance treatment of pulmonary sarcoidosis.
Selroos O; Löfroos AB; Pietinalho A; Niemistö M; Riska H
Sarcoidosis; 1994 Sep; 11(2):126-31. PubMed ID: 7809497
[TBL] [Abstract][Full Text] [Related]
13. Treatments for pulmonary sarcoidosis.
Paramothayan S; Lasserson T
Respir Med; 2008 Jan; 102(1):1-9. PubMed ID: 17954027
[TBL] [Abstract][Full Text] [Related]
14. A case series of 48 patients treated with thalidomide.
Doherty SD; Hsu S
J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of muscle sarcoidosis with thalidomide.
Walter MC; Lochmüller H; Schlotter-Weigel B; Meindl T; Müller-Felber W
Acta Myol; 2003 May; 22(1):22-5. PubMed ID: 12966701
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy.
Maurer T; Poncelet A; Berger T
Arch Dermatol; 2004 Jul; 140(7):845-9. PubMed ID: 15262695
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.
Ordi-Ros J; Cortés F; Cucurull E; Mauri M; Buján S; Vilardell M
J Rheumatol; 2000 Jun; 27(6):1429-33. PubMed ID: 10852265
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus.
Briani C; Zara G; Rondinone R; Iaccarino L; Ruggero S; Toffanin E; Ermani M; Ghirardello A; Zampieri S; Sarzi-Puttini P; Doria A
Autoimmunity; 2005 Nov; 38(7):549-55. PubMed ID: 16373260
[TBL] [Abstract][Full Text] [Related]
19. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
[TBL] [Abstract][Full Text] [Related]
20. Prurigo nodularis of Hyde treated with low-dose thalidomide.
Orlando A; Renna S; Cottone M
Eur Rev Med Pharmacol Sci; 2009; 13(2):141-5. PubMed ID: 19499850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
